Minerva Neurosciences (NERV) Total Debt (2013 - 2018)
Minerva Neurosciences' Total Debt came in at $1.4 million for Q2 2018, down 78.2% from $6.39 million a year earlier and down 48.2% from the prior quarter.
Powered by 
Analysis
Minerva Neurosciences (NERV) Total Debt (2013 - 2018) Analysis & Trends
At the end of FY2017, Minerva Neurosciences' Total Debt was $3.96 million, down 54.4% from FY2016.
- Total Debt carries a four-year compound annual growth rate of 187.2% (FY2013 to FY2017).
- Going back by year, Total Debt was $8.69 million in FY2016 (-12.5%), $9.94 million in FY2015 and $58,270 in FY2013.
- The Q2 2018 figure represents the lowest quarterly Total Debt since Q4 2013.
- Year-over-year, Total Debt has declined for eight consecutive quarters, with an average decline of 39.8% over the last eight quarters.
- The fastest year-over-year change in Total Debt over five years came in Q2 2015 (growth of 188.6%), and the weakest in Q2 2018 (a decline of 78.2%).
- Business Quant data shows NERV's Total Debt at $2.7 million (Q1 2018), $3.96 million (Q4 2017) and $5.19 million (Q3 2017) in the three quarters before Q2 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 49.04 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 70.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 53.91 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 37.49 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -111.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 57.30 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 26.25 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 63.19 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Minerva Neurosciences | 160.57 Mn | 160.57 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2018 | 1.40 Mn |
| Mar 31, 2018 | 2.70 Mn |
| Dec 31, 2017 | 3.96 Mn |
| Sep 30, 2017 | 5.19 Mn |
| Jun 30, 2017 | 6.39 Mn |
| Mar 31, 2017 | 7.56 Mn |
| Dec 31, 2016 | 8.69 Mn |
| Sep 30, 2016 | 9.80 Mn |
| Jun 30, 2016 | 10.10 Mn |
| Mar 31, 2016 | 10.02 Mn |
| Dec 31, 2015 | 9.94 Mn |
| Sep 30, 2015 | 9.86 Mn |
| Jun 30, 2015 | 9.78 Mn |
| Mar 31, 2015 | 9.71 Mn |
| Jun 30, 2014 | 3.39 Mn |
| Dec 31, 2013 | 58,270.00 |
API Access
Minerva Neurosciences Total Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-debt&ticker=NERV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-debt", "ticker": "NERV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-debt&ticker=NERV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();